Northeast Wisconsin Retina Associates

03/19/2026

Retinal vein occlusion (RVO) is a common condition that can cause vision loss if not treated. Advances in therapy are helping doctors manage RVO more effectively, reduce retinal swelling, and protect patients’ vision. Learn more: https://brnw.ch/21x0Sf1

Explore latest RVO care: faricimab, Eylea HD, and biosimilars that cut injection burden and protect vision from macular edema.

03/17/2026

Protecting your vision starts with early and accurate diagnosis. At Northeast Wisconsin Retina Associates, we use advanced retinal testing to detect and monitor conditions like macular degeneration and diabetic retinopathy. Our specialists provide personalized care and guidance every step of the way. Learn more: https://brnw.ch/21x0Odc

03/12/2026

Your vision is our priority at the Oshkosh Retina Center. Our specialists provide comprehensive care for conditions like macular degeneration and diabetic retinopathy, serving patients throughout Northeastern Wisconsin and Upper Michigan. Learn more: https://brnw.ch/21x0Gan

03/10/2026

A new treatment for wet age-related macular degeneration (AMD), AXPAXLI, has shown promising results in clinical trials, helping patients maintain vision longer. The therapy may reduce the number of injections needed, making ongoing care easier and more convenient. Learn more: https://brnw.ch/21x0C0r

The superiority primary endpoint at week 36 was met with high statistical significance, and AXPAXLI showed either statistical significance or numerical superiority to aflibercept (2 mg) in key secondary and prespecified exploratory endpoints.

03/05/2026

We are proud to be there for our patients when they need us most, from urgent appointments to after-hours hospital care. Thank you for trusting us with your vision and for sharing your experience.

03/04/2026

March is National Nutrition Month! Eating a balanced diet not only supports your overall health but also helps protect your eyes. Include colorful fruits and vegetables like carrots, spinach, and bell peppers, as well as omega-3-rich foods like salmon and walnuts, to help maintain good vision.

02/27/2026

The FDA has approved a new eye drop called YUVEZZI from Tenpoint Therapeutics, which can help adults with presbyopia, the common age-related condition that makes it hard to see things up close. It’s the first eye drop designed to improve near vision by gently adjusting the pupil. Learn more: https://brnw.ch/21x0jye

Tenpoint Therapeutics’ YUVEZZI, projected to launch in the US in Q2 2026, represents the first fixed-dose combination eye drop developed to enhance near vision through pupil modulation with once-daily administration.

02/26/2026

Researchers at the University of Washington developed a new eye imaging technique. It lets doctors see how light-sensing cells in the eye respond in real time. This may help detect and monitor eye diseases like macular degeneration and retinitis pigmentosa earlier. Learn more: https://brnw.ch/21x0hMd

Optoretinography is an emerging technology used to test light-evoked photoreceptor activity.

02/25/2026

Opus Genetics launches Phase 1/2 clinical trial of OPGx-MERTK gene therapy for MERTK-related retinitis pigmentosa, marking a potential first step toward altering disease progression. Learn more: https://brnw.ch/21x0fvD

The trial is evaluating OPGx-MERTK gene therapy for MERTK-related retinitis pigmentosa (RP).

02/24/2026

Testimonials like this make our work especially meaningful. They reflect our commitment to timely, compassionate, and expert patient care. Providing excellent outcomes during urgent situations remains our top priority.

02/23/2026

Meet Swati Agarwal-Sinha, MD, FASRS, a fellowship-trained retina specialist with expertise in adult and pediatric retinal diseases. Dr. Agarwal-Sinha combines advanced, evidence-based care with a strong commitment to patient-centered treatment. Learn more: https://brnw.ch/21x0cdz

02/20/2026

Researchers highlight growing evidence that the eye can serve as a window to systemic disease, showing that retinal imaging and transient visual symptoms may enable earlier detection of serious pulmonary and cardiovascular conditions through noninvasive ocular evaluation. Learn more: https://brnw.ch/21x07ps

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.